Table 3 TMEM79 and SMG5 expression by clinicopathological characteristics of patients with HCC
Characteristics | n | TMEM79 (%) | χ2 | P | SMG5 (%) |  |  | ||
|---|---|---|---|---|---|---|---|---|---|
Low or none | High | Low or none | High | χ2 | P | ||||
Gender | Â | 113 (40.1) | 169 (59.9) | 0.016 | 0.507 | 99 (35.1) | 183 (64.9) | 0.095 | 0.432 |
 Male | 71 | 28 (39.4) | 43 (60.6) |  |  | 26 (36.6) | 45 (63.4) |  |  |
 Female | 211 | 85 (40.3) | 126 (59.7) |  |  | 73 (34.6) | 138 (65.4) |  |  |
Age (years) | Â | 113 (40.1) | 169 (59.9) | 0.024 | 0.493 | 99 (35.1) | 183 (64.9) | 3.049 | 0.056 |
 < 60 | 211 | 84 (39.8) | 127 (60.2) |  |  | 68 (32.2) | 143 (67.8) |  |  |
 ≥ 60 | 71 | 29 (40.8) | 42 (59.2) |  |  | 31 (43.7) | 40 (56.3) |  |  |
Tumor diameter (cm) | Â | 113 (40.1) | 169 (59.9) | 1.289 | 0.156 | 99 (35.1) | 183 (64.9) | 0.685 | 0.243 |
  < 5 | 176 | 66 (37.5) | 110 (62.5) |  |  | 65 (36.9) | 111 (63.1) |  |  |
 ≥ 5 | 106 | 47 (44.3) | 59 (55.7) |  |  | 34 (32.1) | 72 (67.9) |  |  |
AFP (μg/L) |  | 113 (40.1) | 169 (59.9) | 0.025 | 0.492 | 99 (35.1) | 183 (64.9) | 0.291 | 0.345 |
 < 400 | 216 | 86 (39.8) | 130 (60.2) |  |  | 74 (34.3) | 142 (65.7) |  |  |
 ≥ 400 | 66 | 27 (40.9) | 39 (59.1) |  |  | 25 (37.9) | 41 (62.1) |  |  |
Tumor number | Â | 113 (40.1) | 169 (59.9) | 2.654 | 0.071 | 99 (35.1) | 183 (64.9) | 5.848 | 0.010a |
 Solitary | 243 | 102 (42.0) | 141 (58.0) |  |  | 92 (37.9) | 151 (62.1) |  |  |
 Multiple | 39 | 11 (28.2) | 28 (71.8) |  |  | 7 (17.9) | 32 (82.1) |  |  |
TNM stage |  | 113 (40.1) | 169 (59.9) | 22.021 |  < 0.001a | 99 (35.1) | 183 (64.9) | 15.918 | 0.001a |
 I | 193 | 91 (47.2) | 102 (52.8) |  |  | 77 (39.9) | 116 (60.1) |  |  |
 II | 53 | 20 (37.7) | 33 (62.3) |  |  | 20 (37.7) | 33 (62.3) |  |  |
 III | 15 | 1 (6.7) | 14 (93.3) |  |  | 1 (6.7) | 14 (93.3) |  |  |
 IV | 21 | 1 (4.8) | 20 (95.2) |  |  | 1 (4.8) | 20 (95.2) |  |  |
T | Â | 113 (40.1) | 169 (59.9) | 13.464 | 0.004a | 99 (35.1) | 183 (64.9) | 9.918 | 0.019a |
 1 | 193 | 90 (46.6) | 103 (53.4) |  |  | 77 (39.9) | 116 (60.1) |  |  |
 2 | 71 | 21 (29.6) | 50 (70.4) |  |  | 21 (29.6) | 50 (70.4) |  |  |
 3 | 12 | 2 (16.7) | 10 (83.3) |  |  | 1 (8.3) | 11 (91.7) |  |  |
 4 | 6 | 0 (0.0) | 6 (100.0) |  |  | 0 (0.0) | 6 (100.0) |  |  |
N | Â | 113 (40.1) | 169 (59.9) | 0.395 | 0.417 | 99 (35.1) | 183 (64.9) | 0.135 | 0.529 |
 0 | 275 | 111 (40.4) | 164 (59.6) |  |  | 97 (35.3) | 178 (64.7) |  |  |
 1 | 7 | 2 (28.6) | 5 (71.4) |  |  | 2 (28.6) | 5 (71.4) |  |  |
M |  | 113 (40.1) | 169 (59.9) | 11.026 | < 0.001a | 99 (35.1) | 183 (64.9) | 8.565 | 0.002a |
 0 | 262 | 112 (42.7) | 150 (57.3) |  |  | 98 (37.4) | 164 (62.6) |  |  |
 1 | 20 | 1 (5.0) | 19 (95.0) |  |  | 1 (5.0) | 19 (95.0) |  |  |
Differentiation | Â | 113 (40.1) | 169 (59.9) | 1.944 | 0.378 | 99 (35.1) | 183 (64.9) | 4.949 | 0.084 |
 Well | 33 | 11 (33.3) | 22 (66.7) |  |  | 17 (51.5) | 16 (48.5) |  |  |
 Moderate | 159 | 61 (38.4) | 98 (61.6) |  |  | 55 (34.6) | 104 (65.4) |  |  |
 Poor | 90 | 41 (45.6) | 49 (54.4) |  |  | 27 (30.0) | 63 (70.0) |  |  |
Hepatitis B virus infection | Â | 113 (40.1) | 169 (59.9) | 1.210 | 0.199 | 99 (35.1) | 183 (64.9) | 1.872 | 0.134 |
 No | 18 | 5 (27.8) | 13 (72.2) |  |  | 9 (50.0) | 9 (50.0) |  |  |
 Yes | 264 | 108 (40.9) | 156 (59.1) |  |  | 90 (34.1) | 174 (65.9) |  |  |
Vascular invasion | Â | 113 (40.1) | 169 (59.9) | 7.094 | 0.005a | 99 (35.1) | 183 (64.9) | 0.381 | 0.328 |
 No | 231 | 101 (43.7) | 130 (56.3) |  |  | 83 (35.9) | 148 (64.1) |  |  |
 Yes | 51 | 12 (23.5) | 39 (76.5) |  |  | 16 (31.4) | 35 (68.6) |  |  |
Liver cirrhosis | Â | 113 (40.1) | 169 (59.9) | 2.202 | 0.087 | 99 (35.1) | 183 (64.9) | 0.950 | 0.198 |
 No | 137 | 61 (44.5) | 76 (55.5) |  |  | 52 (38.0) | 85 (62.0) |  |  |
 Yes | 145 | 52 (35.9) | 93 (64.1) |  |  | 47 (32.4) | 98 (67.6) |  |  |
Recurrence | Â | 113 (40.1) | 169 (59.9) | 7.667 | 0.004a | 99 (35.1) | 183 (64.9) | 0.526 | 0.289 |
 No | 230 | 101 (43.9) | 129 (56.1) |  |  | 83 (36.1) | 147 (63.9) |  |  |
 Yes | 52 | 12 (23.1) | 40 (76.1) |  |  | 16 (30.8) | 36 (69.2) |  |  |